Innovation doesn’t stop when sourcing capital gets tough. It finds new paths.
Traditional venture capital isn’t fueling innovation the way it once did, pushing companies to explore new paths from breakthrough ideas to commercial reality.
Triple Ring’s Ryan McGuinness will represent Triple Ring at LSI Asia 2026 and moderate a panel exploring emerging finance models aiming to fill that gap.
Joining Ryan in this discussion:
- Robert King, 1540 Ventures
- David Sharrow, Orrick, Herrington & Sutcliffe LLP
Together, they’ll examine the strategies reshaping how healthcare technologies reach the market, including corporate venture capital, Build-to-Buy models, IP-backed financing, family office investment, and government-supported innovation funds.
The future of MedTech won’t be built by a single funding model. It will be built through new forms of collaboration between innovators, investors, strategics, and industry partners.
Looking forward to the conversations ahead in Singapore.
